GT316

Clinical trials for GT316 explained in plain language.

Never miss a new study

Get alerted when new GT316 trials appear

Sign up with your email to follow new studies for GT316, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Experimental immune cell therapy for advanced cancers shows early safety data

Disease control Terminated

This early-phase study tested a personalized cell therapy made from a patient's own tumor-fighting immune cells. It aimed to see if the treatment was safe for people with advanced solid tumors that had spread or come back. Only 2 people took part before the study was stopped earl…

Matched conditions: GT316

Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control

Last updated Jun 27, 2026 12:25 UTC

GT316

Get alerted when new GT316 trials appear

Experimental immune cell therapy for advanced cancers shows early safety data